NCT03127852
- Conditions
- Cardiovascular Diseases, Chronic Disease, Chronic Kidney Disease, +25 more
- Locations
-
- University Health Network Toronto, Ontario, Canada
Clinical trial condition
Kidney Diseases
Explore clinical trials studying Kidney Diseases. Study availability and eligibility vary by location and protocol.
8,905 public trials
1,418 recruiting studies
Kidney Diseases trial results
NCT03774394
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +26 more
- Locations
-
- University of Florida Jacksonville Jacksonville, Florida, United States
NCT01770951
- Conditions
- Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +15 more
- Locations
-
- Dunwoody, Georgia, United States
- Chicago, Illinois, United States
- Portland, Maine, United States
- Boston, Massachusetts, United States
NCT05025748
- Conditions
- Adnexal Diseases, Breast Diseases, Breast Neoplasms, +68 more
- Locations
-
- Karmanos Cancer Institute at McLaren Bay Region Bay City, Michigan, United States
- Karmanos Cancer Institute at McLaren Clarkston Clarkston, Michigan, United States
- Karmanos Cancer Institute Detroit, Michigan, United States
- Karmanos Cancer Institute at McLaren Flint Flint, Michigan, United States
NCT01029002
- Conditions
- Chronic Disease, Chronic Renal Insufficiency, Disease Attributes, +14 more
- Locations
-
- Montefiore medical center The Bronx, New York, United States
NCT03519347
- Conditions
- Arrhythmias, Cardiac, Cardiovascular Diseases, Chronic Disease, +14 more
- Locations
-
- Duke University School of Medicine Durham, North Carolina, United States
NCT04958759
- Conditions
- Chronic Disease, Chronic Kidney Diseases, Disease Attributes, +10 more
- Locations
-
- Hacettepe University, Faculty of Physical Therapy and Rehabilitation Ankara, Turkey (Türkiye)
Completed
OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors
NCT00471432
- Conditions
- Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +49 more
- Locations
-
Not specified
NCT00075660
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- British Columbia Cancer Agency Vancouver, British Columbia, Canada
- CancerCare Manitoba Winnipeg, Manitoba, Canada
- Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada
Completed
Stereotactic Radiotherapy and Anti-PD1 Antibody (Pembrolizumab) for Oligometastatic Renal Tumours
NCT02855203
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Princess Alexandra Hospital Woolloongabba, Queensland, Australia
- Peter MacCallum Cancer Centre Melbourne, Victoria, Australia